2637

Fujian Haixi Pharmaceuticals Co., Ltd. Stock Price

SEHK:2637 Community·HK$9.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2637 Share Price Performance

HK$121.00
16.80 (16.12%)
HK$121.00
16.80 (16.12%)
Price HK$121.00

2637 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with questionable track record.

2 Risks
1 Reward

Fujian Haixi Pharmaceuticals Co., Ltd. Key Details

CN¥466.7m

Revenue

CN¥79.5m

Cost of Revenue

CN¥387.2m

Gross Profit

CN¥251.1m

Other Expenses

CN¥136.1m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
1.73
82.97%
29.16%
9.2%
View Full Analysis

About 2637

Founded
2012
Employees
164
CEO
Xinshan Kang
WebsiteView website
www.hxpharma.com

Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. The company was incorporated in 2012 and is based in Fuzhou, China.

Recent 2637 News & Updates

Recent updates

No updates